Exercise improves cognition in Parkinson's disease: The PRET-PD randomized, clinical trial
- PMID: 26148003
- PMCID: PMC4609235
- DOI: 10.1002/mds.26291
Exercise improves cognition in Parkinson's disease: The PRET-PD randomized, clinical trial
Abstract
Background: This article reports on the findings of the effect of two structured exercise interventions on secondary cognitive outcomes that were gathered as part of the Progressive Resistance Exercise Training in Parkinson's disease (PD) randomized, controlled trial.
Methods: This study was a prospective, parallel-group, single-center trial. Fifty-one nondemented patients with mild-to-moderate PD were randomly assigned either to modified Fitness Counts (mFC) or to Progressive Resistance Exercise Training (PRET) and were followed for 24 months. Cognitive outcomes were the Digit Span, Stroop, and Brief Test of Attention (BTA).
Results: Eighteen patients in mFC and 20 patients in PRET completed the trial. At 12 and at 24 months, no differences between groups were observed. At 12 months, relative to baseline, mFC improved on the Digit Span (estimated change: 0.3; interquartile range: 0, 0.7; P = 0.04) and Stroop (0.3; 0, 0.6; P = 0.04), and PRET improved only on the Digit Span (0.7; 0.3, 1; P < 0.01). At 24 months, relative to baseline, mFC improved on the Digit Span (0.7; 0.3, 1.7; P < 0.01) and Stroop (0.3; 0.1, 0.5; P = 0.03), whereas PRET improved on the Digit Span (0.5; 0.2, 0.8; P < 0.01), Stroop (0.2; -0.1, 0.6; P = 0.048), and BTA (0.3; 0, 0.8; P = 0.048). No neurological or cognitive adverse events were observed.
Conclusions: This study provides class IV level of evidence that 24 months of PRET or mFC may improve attention and working memory in nondemented patients with mild-to-moderate Parkinson's disease.
Trial registration: ClinicalTrials.gov NCT00591344.
Keywords: Parkison's disease; attention; memory; progressive resistance exercise; randomized controlled trial.
© 2015 International Parkinson and Movement Disorder Society.
Figures
References
-
- Brown RG, Marsden CD. Cognitive function in parkinsons-disease - from description to theory. Trends Neurosci. 1990;13(1):21–29. - PubMed
-
- Cooper JA, Sagar HJ, Jordan N, Harvey NS, Sullivan EV. Cognitive impairment in early, untreated parkinsons-disease and its relationship to motor disability. Brain. 1991;114:2095–2122. - PubMed
-
- Owen AM. Cognitive dysfunction in parkinson disease: The role of frontostriatal circuitry. Neuroscientist. 2004;10(6):525–537. ER. - PubMed
-
- Kudlicka A, Clare L, Hindle JV. Executive functions in parkinson's disease: Systematic review and meta-analysis. Mov Disord. 2011;26(13):2305–2315. [doi]. - PubMed
-
- Owen AM, James M, Leigh PN, et al. Fronto-striatal cognitive deficits at different stages of parkinsons-disease. Brain. 1992;115:1727–1751. - PubMed
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
